Apollo Management Holdings, L.P. Coherus Bio Sciences, Inc. Transaction History

Apollo Management Holdings, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 15, 2019	SELL	$8.65 - $16.28 $1.95 Million - $3.66 Million	-225,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.45 - $20.25 $1.81 Million - $2.53 Million	125,000 Added 125.0%	225,000 $3.71 Million
Q2 2018 Aug 14, 2018	BUY	$10.25 - $17.45 $1.03 Million - $1.75 Million	100,000 New	100,000 $1.4 Million

132

76.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Apollo Management Holdings, L.P., based on Form 13F filings with the SEC.

Stay updated on Apollo Management Holdings, L.P. with notifications on news.